Skip to main content

Advertisement

Log in

Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial

  • Basic Science
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

The management of chronic ocular hypotony and complicated proliferative vitreoretinopathy-related retinal detachment represents a challenge. Being non-absorbable and non-biodegradable, a silicone oil implant is expected to restore the volume and the intraocular pressure of the globe, as well as to approximate the detached retina. Further advantages could be a long-term tamponade potential, absence of toxicity, and prevention of silicone oil emulsification or anterior chamber oil-prolapse. The aim of this study was to assess the histological tolerance of the silicone oil implant in a pig model.

Methods

A seamless silicone balloon implant with optional surface modifications was developed. Mini pigs were used as experimental animals, and three variants of silicone implants with different surfaces were tested: uncoated, NCO-sP(EO-stat-PO) coated, and heparin-NCO-sP(EO-stat-PO) coated silicone implants. An extracapsular lens extraction was achieved via a standard phacoemulsification followed by a standard three-port vitrectomy. The implant was then placed in the posterior segment and filled with 5000 centistoke silicone oil. One month later, the pigs were euthanized, the eyes were enucleated, and histological specimens were prepared for microscopy.

Results

The analysis of the histology revealed that adverse histological changes in conjunctiva, cornea, iris, and ciliary body could be excluded in all eyes operated on regardless of which variant of implant had been employed. The retina as the implant-contacting ocular tissue showed overall good tolerance, although some inflammatory reaction and fibrous proliferation was evident in some cases.

Conclusions

The silicone oil implant is a promising candidate and has the potential to fulfill clinical requirements to act as a long-term intraocular tamponade agent. The heparin-NCO-sP(EO-stat-PO) coating approach could lead to a novel bioactive surface for intraocular devices with excellent properties to hinder cell adhesion and protein adsorption, although further studies will be necessary to evaluate long-term biocompatibility and long-term resistance to biological attacks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Jonas JB, Vossmerbaeumer U, Kamppeter BA (2004) Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 82(5):637

    Article  PubMed  Google Scholar 

  2. Arevalo JF, Garcia RA, Fernandez CF (2004) Anterior segment inflammation and hypotony after posterior segment surgery. Ophthalmol Clin N Am 17(4):527–537

    Article  Google Scholar 

  3. De Smet MD, Gunning F, Feenstra R (2005) The surgical management of chronic hypotony due to uveitis. Eye (Lond) 19(1):60–64

    Article  Google Scholar 

  4. Tosi GM, Schiff W, Barile G, Yoshida N, Chang S (2005) Management of severe hypotony with intravitreal injection of viseoeplastic. Am J Ophthalmol 140(5):952–954

    Article  PubMed  Google Scholar 

  5. Küçükerdönmez C, Beutel J, Bartz-Schmidt KU, Gelisken F (2009) Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol 93(2):235–239. doi:10.1136/bjo.2008.143834.

    Article  PubMed  Google Scholar 

  6. Kapur R, Birnbaum AD, Goldstein DA, Tessler HH, Shapiro MJ, Ulanski LJ, Blair MP (2010) Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina 30(1):140–145. doi:10.1097/IAE.0b013e3181b32f06

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cadera W, Harding PW, Gonder JR, Hooper PL (1993) Management of severe hypotony with intravitreal injection of Healon. Can J Ophthalmol 28(5):236–237

    CAS  PubMed  Google Scholar 

  8. Giuffrè I, Taverniti L, Di Staso S (2004) The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma. Eur J Ophthalmol 14(6):508–513

    PubMed  Google Scholar 

  9. Schramm C, Spitzer M, Henke-Fahle S, Steinmetz G, Januschowski K, Heiduschka P, Geis-Gerstorfer J, Biedermann T, Bartz-Schmidt K, Szurman P (2012) The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute. Invest Ophthalmol Vis Sci 53(2):613–621. doi:10.1167/iovs.11-7322

    Article  CAS  PubMed  Google Scholar 

  10. Bayoudh W, Frentz M, Carstesen D, Dittrich B, Reismann C, Schrage NF, Walter P, Weinberger AW (2016) Intraocular silicone implant to treat chronic ocular hypotony-preliminary feasibility data. Graefes Arch Clin Exp Ophthalmol 254(11):2131–2139

    Article  CAS  PubMed  Google Scholar 

  11. Fischer S, Carstesen D, Klee D, Walter P, Weinberger AW (2012) Surface-modified silicone foils for intraocular implantation. Graefes Arch Clin Exp Ophthalmol 250(6):823–827. doi:10.1007/s00417-012-1956-1.

    Article  CAS  PubMed  Google Scholar 

  12. Bartzoka V, McDermott MR, Brook MA (1999) Protein-silicone interactions. Adv Mater 11(3):257–259

    Article  CAS  Google Scholar 

  13. Groll J, Ameringer T, Spatz JP, Moeller M (2005) Ultrahin coatings form isocyanate- terminated star PEG prepolymers: layer formation and characterization. Langmuir 21(5):1991–1999

    Article  CAS  PubMed  Google Scholar 

  14. Heyes CD, Groll J, Möller M, Nienhaus GU (2007) Synthesis, patterning and applications of star-shaped poly(ethylene glycol) biofunctionalized surfaces. Mol BioSyst 3(6):419–430

    Article  CAS  PubMed  Google Scholar 

  15. Nagahama K, Saito T, Quchi T, Ohya Y (2011) Biodegradable nano-aggregates of star-shaped 8-arm PEG-PLLA block co-polymers for encapsulation of water-soluble macromolecules. J Biomater Sci Polym Ed 22(1–3):407–416

    Article  CAS  PubMed  Google Scholar 

  16. Satulovsky J, Caringano MA, Szleifer I (2000) Kinetic and thermodynamic control of protein adsorption. Proc Natl Acad Sci 97:9037–9041

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Wakefield D, Cuello C, Di Girolamo N, Lloyd A (1999) The role of cytokines and chemokines in uveitis. Dev Ophthalmol 31:53–66

    Article  CAS  PubMed  Google Scholar 

  18. Magone MT, Whitcup SM (1999) Mechanisms of intraocular inflammation. Chem Immunol 73:90–119

    Article  CAS  PubMed  Google Scholar 

  19. Keller GK, Dahlke C, Kuckelkorn R, Schrage N (2003) Experience with the artificial iris diaphragm in hypotonic eyes. Ophthalmologe 100(3):203–208

    Article  CAS  PubMed  Google Scholar 

  20. Miller JB, Papakostas TD, Vavvas DG (2014) Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol 29(5–6):312–318

    Article  PubMed  Google Scholar 

  21. Furmanski J, Anderson M, Bal S, Greenwald AS, Halley D, Penenberg B, Ries M, Pruitt L (2009) Clinical fracture of cross-linked UHMWPE acetabular liners. Biomaterials 30(29):5572–5582. doi:10.1016/j.biomaterials.2009.07.013

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wesal Bayoudh.

Ethics declarations

Funding

The Interdisciplinary Centre for Clinical Research “BIOMAT” and the START program, both within the faculty of Medicine at the RWTH Aachen University, provided financial support in the form of grant funding. The sponsor had no role in the design or conduct of this research.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers’ bureaus, membership, employment, consultancies, stock ownership, other equity interest, expert testimony, or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayoudh, W., Carstesen, D., Walter, P. et al. Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial. Graefes Arch Clin Exp Ophthalmol 255, 1947–1955 (2017). https://doi.org/10.1007/s00417-017-3714-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-017-3714-x

Keywords

Navigation